Mauro Viganò

13PUBLICATIONS
69CO-AUTHORS
Metabolic medicineCardiology (incl. cardiovascular diseases)Predictive and prognostic markersPolitical economy and social changeMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 23, 2026
MASLD In PBC: A Shift From Liver-Centred to Cardiometabolic Risk Assessment?

|Apr 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study.

|Feb 27, 2026
RETREAT Score Accurately Predicts the Long-Term Risk of HCC Recurrence After Liver Transplantation: A Single-Center Real-Life Validation.

Flavia Neri, Mauro Viganò, Stefania Camagni

|Sep 04, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.

Alessandro Loglio, Ivan Gardini, Massimiliano Conforti

|Feb 26, 2025
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.

Luca Rinaldi, Mauro Viganò, Alessia Ciancio

|Jan 11, 2025
Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives.

Alberto Savino, Alberto Rossi, Stefano Fagiuoli

Pageof 3

Frequent Collaborators

7 joint publications

Alessandro Loglio

6 joint publications

Stefano Fagiuoli

3 joint publications

Pietro Invernizzi

3 joint publications

Pietro Lampertico